The haplotype of two FSHR polymorphisms in ovarian cancer- A potential role of ethnology in risk modification

Gynecologic Oncology

Volumn 112, Issue 3, 2009, Pages 486-489

  Heubner, Martin ^a   Riemann, Kathrin ^a   Otterbach, Friedrich ^a   Kimmig, Rainer ^a   Kasimir Bauer, Sabine ^a   Siffert, Winfried ^a   Wimberger, Pauline ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARAGINE; CA 125 ANTIGEN; FOLLITROPIN RECEPTOR; SERINE; THREONINE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; DISEASE COURSE; EPITHELIAL OVARIAN CANCER; EPITHELIUM TUMOR; ETHNOLOGY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; GROUPS BY AGE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, FSH; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 60449117010     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.12.011     Document Type: Article

References (29)

1. Goodman M.T., Howe H.L., Tung K.H., Hotes J., Miller B.A., Coughlin S.S., et al. Incidence of ovarian cancer by race and ethnicity in the United States, 1992-1997. Cancer 97 10 Suppl (2003) 2676-2685
2. Risch H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer. Inst. 90 23 (1998) 1774-1786
3. Syed V., Ulinski G., Mok S.C., Yiu G.K., and Ho S.M. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer. Res. 61 18 (2001) 6768-6776
4. Arslan A.A., Zeleniuch-Jacquotte A., Lundin E., Micheli A., Lukanova A., Afanasyeva Y., et al. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 12 12 (2003) 1531-1535
5. Longo D.L., and Young R.C. The natural history and treatment of ovarian cancer. Annu. Rev. Med. 32 (1981) 475-490
6. Schildkraut J.M., Schwingl P.J., Bastos E., Evanoff A., and Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet. Gynecol. 88 4 Pt 1 (1996) 554-559
7. Halperin R., Hadas E., Bukovsky I., and Schneider D. Peritoneal fluid analysis in the differentiation of ovarian cancer and benign ovarian tumor. Eur. J. Gynaecol. Oncol. 20 1 (1999) 40-44
8. Rzepka-Gorska I., Chudecka-Glaz A., and Kosmowska B. FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary. Endocr. Relat. Cancer. 11 2 (2004) 315-321
9. Adams J.M., and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281 5381 (1998) 1322-1326
10. Parrott J.A., Doraiswamy V., Kim G., Mosher R., and Skinner M.K. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Mol. Cell. Endocrinol. 172 1-2 (2001) 213-222
11. Wang J., Lin L., Parkash V., Schwartz P.E., Lauchlan S.C., and Zheng W. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems. Int. J. Cancer 103 3 (2003) 328-334
12. Choi J.H., Choi K.C., Auersperg N., and Leung P.C. Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells. Endocr. Relat. Cancer 12 2 (2005) 407-421
13. Ji Q., Liu P.I., Chen P.K., and Aoyama C. Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells. Int. J. Cancer. 112 5 (2004) 803-814
14. Rzepka-Gorska I., Blogowska A., Zajaczek S., and Zielinska D. [Germinal cell tumors in young and adolescent girls]. Ginekol. Pol. 74 9 (2003) 840-846
15. Sugiyama M., Imai A., Takahashi S., Hirano S., Furui T., and Tamaya T. Advanced indications for gonadotropin-releasing hormone (GnRH) analogues in gynecological oncology (review). Int. J. Oncol. 23 2 (2003) 445-452
16. Verschraegen C.F., Westphalen S., Hu W., Loyer E., Kudelka A., Volker P., et al. Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer. Gynecol. Oncol. 90 3 (2003) 552-559
17. Yang C.Q., Chan K.Y., Ngan H.Y., Khoo U.S., Chiu P.M., Chan Q.K., et al. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis 27 7 (2006) 1502-1506
18. de Castro F., Ruiz R., Montoro L., Perez-Hernandez D., Sanchez-Casas P.E., Real L.M., et al. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil. Steril. 80 3 (2003) 571-576
19. Perez M.M., Gromoll J., Behre H.M., Gassner C., Nieschlag E., and Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J. Clin. Endocrinol. Metab. 85 9 (2000) 3365-3369
20. Lee K.R., Tavassoli F.A., Prat J., et al. Surface epithelial-stromal tumours. World Health Organization classification of tumours. Tumours of the breast and female genital organs (2003), IARC Press, Lyon 117-145
21. Silverberg S.G. Histopathologic grading of ovarian carcinoma: a review and proposal. Int. J. Gynecol. Pathol. 19 1 (2000) 7-15
22. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 2 (2005) 263-265
23. The International HapMap Project. Nature 426 6968 (2003) 789-796
24. Conway G.S., Conway E., Walker C., Hoppner W., Gromoll J., and Simoni M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin. Endocrinol. (Oxf). 51 1 (1999) 97-99
25. da Fonte Kohek M.B., Batista M.C., Russell A.J., Vass K., Giacaglia L.R., Mendonca B.B., et al. No evidence of the inactivating mutation (C566T) in the follicle-stimulating hormone receptor gene in Brazilian women with premature ovarian failure. Fertil. Steril. 70 3 (1998) 565-567
26. Liu J.Y., Gromoll J., Cedars M.I., and La Barbera A.R. Identification of allelic variants in the follicle-stimulating hormone receptor genes of females with or without hypergonadotropic amenorrhea. Fertil. Steril. 70 2 (1998) 326-331
27. Tong Y., Liao W.X., Roy A.C., and Ng S.C. Absence of mutations in the coding regions of follicle-stimulating hormone receptor gene in Singapore Chinese women with premature ovarian failure and polycystic ovary syndrome. Horm. Metab. Res. 33 4 (2001) 221-226
28. Sudo S., Kudo M., Wada S., Sato O., Hsueh A.J., and Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol. Hum. Reprod. 8 10 (2002) 893-899
29. Makar A.P. Hormone therapy in epithelial ovarian cancer. Endocr. Relat. Cancer. 7 2 (2000) 85-93